0001209191-23-059885.txt : 20231228
0001209191-23-059885.hdr.sgml : 20231228
20231228160011
ACCESSION NUMBER: 0001209191-23-059885
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231226
FILED AS OF DATE: 20231228
DATE AS OF CHANGE: 20231228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCCORMICK FRANK
CENTRAL INDEX KEY: 0001257809
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38959
FILM NUMBER: 231522701
MAIL ADDRESS:
STREET 1: C/O UCSF, 1450 3RD STREET
STREET 2: RM HD-371
CITY: SAN FRANCISCO
STATE: CA
ZIP: 941439001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BridgeBio Pharma, Inc.
CENTRAL INDEX KEY: 0001743881
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3160 PORTER DR.
STREET 2: SUITE 250
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: (650) 391-9740
MAIL ADDRESS:
STREET 1: 3160 PORTER DR.
STREET 2: SUITE 250
CITY: PALO ALTO
STATE: CA
ZIP: 94304
FORMER COMPANY:
FORMER CONFORMED NAME: BridgeBio Pharma LLC
DATE OF NAME CHANGE: 20180618
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-26
0
0001743881
BridgeBio Pharma, Inc.
BBIO
0001257809
MCCORMICK FRANK
C/O BRIDGEBIO
3160 PORTER DR., SUITE 250
PALO ALTO
CA
94304
1
0
0
0
1
Common Stock
2023-12-26
4
S
0
100000
42.06
D
627689
I
See Footnote
Common Stock
472376
D
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person, as Trustee of the Francis P. McCormick Rev Trust U/A DTD 1/27/2017 on June 15, 2023.
Represents the weighted average sale price of the shares sold from $42.00 to $42.25 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017.
/s/ Brian C. Stephenson, Attorney-in-Fact
2023-12-28